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COMPARISON OF ECHOCARDIOGRAPHIC MEASUREMENTS BEFORE
AND AFTER SHORT AND LONG DURATION SPACEFLIGHT
ABSTRACT
Previous echocardiography studies in astronauts before and after short duration (4 - 17 days)
missions have demonstrated a decrease in resting left ventricular (LV) stroke volume (SV), but
maintained ejection fraction (EF) and cardiac output. Similar studies before and after long
duration (129 - 144 days) spaceflight have been rare and their overall results equivocal. The
purpose of this work was to compare the echocardio graphic measurements (M-mode, 2-D and
Doppler) from short duration (n = 13) and long duration (n = 4) crewmembers. Compared to
short duration astronauts, long duration crewmembers had a significantly greater percent
decrease in EF (+6 ± 0.02 vs.-10.5 ± 0.03, p = 0.005) and percent fractional shortening (+7 +
0.03 vs. —11 + 0.07, p = 0.0 15), and an increase in LV end systolic volume (-12 + 0.06 vs. +39 ±
0.24, p = 0.011). These data suggest a reduction in cardiac function that relates to mission
duration. As the changes in blood pressure and circulating blood volume (9% — 12%) are
reported to be similar after short and long duration flights, the drop in EF after longer
spaceflights is likely due to a decrease in cardiac function rather than altered blood volume.
Key words: spaceflight, deconditioning, echocardiography
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Cardiovascular deconditioning (loss of adaptive capacity) in microgravity has long been an issue
associated with human spaceflight (1-6). Operational concerns such as crewmember fitness and
physical performance are critical determinants of mission success. While mission durations of 4-
17 days have been typical in the Space Shuttle program, a smaller number of cosmonauts and
astronauts have flown longer missions (>129 days) aboard the Russian Mir Space Station. These
longer missions will become more common beginning in the year 2001, when crewmembers will
be assigned to tours of duty of 90 days or more on the International Space Station. The
International Space Station crewmembers will have to perform strenuous extravehicular
activities to construct and maintain the station. In potential exploratory missions to Mars and
beyond, humans will face increasingly longer exposures to microgravity. A mission to Mars, as
currently envisioned, would involve significant physical challenges during extravehicular
activity on' the planet after having spent several months in microgravity deconditioning during
the journey.
In addition to these in-flight physiological challenges, current requirements of all Space
Shuttle crewmembers include the ability to egress the Shuttle to a safe distance in the event of an
emergency landing. Significant microgravity-induced cardiac deconditioning, along with
symptomatic orthostatic intolerance, may render this already demanding activity unfeasible.
Approximately 20% of all astronauts do not successfully complete a standard tilt test (10 minutes
at an 80° upright tilt) following landing because they experience orthostatic intolerance (7). This
intolerance appears to be greatly exacerbated with increased mission durations, as 83% of
astronauts returning from long duration missions could not complete a standard tilt test (7).
Whether significant decrements in cardiac function will further compromise performance of
these activities during and after long duration flight is not known. Although orthostatic tolerance
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is influenced by cardiac performance, cardiac functional decrements have not been shown to be a
major contributing factor following short duration flight (2). Nevertheless, the sustained lack of
a gravitational challenge during long duration missions might adversely influence myocardial
function due to the decreased workload on the heart.
To date, echocardiographic data obtained before and after short duration Shuttle flights have
demonstrated preservation of cardiac functional parameters. It has been shown that short
duration spaceflight is associated with decreased left ventricular (LV) stroke volume (SV); yet,
ejection fraction (EF) and cardiac output were not decreased at rest postflight (2-4). Although
echocardiographic data have been obtained within 24 hours of landing following long duration
flights, we know of no prior reported ultrasound data obtained within the immediate postflight
period (within 3 hours of landing) for these longer missions (8). The need for early data
acquisition is important, as immediate clinical performance during this critical time period is a
practical operational concern. It has also been noted that changes in some cardiovascular
measurements have been shown to resolve within 48 hours of landing (2).
The purpose of this study was to determine if preflight to postflight echocardiographic
findings were significantly different following long duration when compared to short duration
spaceflight.
METHODS
Seventeen male astronaut subjects, ages ranging from 34 to 48 years, underwent
echocardiography preflight and immediately postflight. Thirteen subjects flew on short duration
Space Shuttle missions (4 - 17 days) and 4 flew on long duration missions (129 - 144 days). This
study was approved by the Johnson Space Center Institutional Review Board.
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Data were obtained approximately 10 days prior to flight, within 3 hours of landing, and 3 to
10 days postflight. Identical Biosound Genesis II (Biosound, Indianapolis, IN)
echocardiographic systems were used for all data acquisition. Views and measurements used
were consistent with the American Society of Echocardiography standards. Views included
parasternal long axis and apical, with subjects in the left lateral decubitus position. M-modes
were obtained from the parasternal long axis view. Following videotape recording, 4 frames of
each M-mode were stored digitally for off-line analysis. Doppler measurements included mitral
inflow recorded at the tips of the mitral leaflets. LV outflow Doppler was obtained from the
apical window. Pulsed Doppler of the ascending aortic flow was obtained through the
suprasternal approach. Three frames of each Doppler spectrum were stored digitally. All stored
images were analyzed and averaged by 2 observers on either a Kodak-Microsonics ImageVue
DCR or Microsonics DataVue II workstation (Indianapolis, N. Parameters were selected based
on functional relevance.
Ejection fraction was calculated as (LV end diastolic volume - LV end systolic volume)/LV
end diastolic volume. Mass was calculated as 1.04 x [(diastolic interventricular septal thickness +
diastolic LV posterior wall thickness + LV diastolic diameter) 3 - (LV diastolic diameter) 3 ] - 13.6.
LV fractional shortening was calculated as (LV diastolic diameter - LV systolic diameter)/LV
end diastolic diameter x 100. The calculation for LV volume was volume = (7.0/(2.4 + LV
diastolic diameter)) LV diastolic diameter  (9). A Mama-Whitney Rank Sum Test was employed
and significance determined by a p value of <0.05 when comparing short and long duration
groups. Statistical values were calculated for percent changes for preflight to landing day and
are presented as the mean + standard error. Paired t tests were employed to determine the
significance between days within each group. Significance was determined by a p value of
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<0.05.
RESULTS
Table I shows the preflight, landing day, and recovery data for all subjects. Table II shows
the percent change between preflight and landing day for both short and long duration flight. In
contrast to short duration crewmembers who had a decrease in LV systolic volume and an
increase in EF, long duration crewmembers showed an increase in LV systolic volume and a
corresponding decrease in EF. In comparing short duration to long duration, the percent changes
for preflight vs. landing day were statistically significant for LV systolic diameter (p = 0.025),
LV systolic volume (p = 0.011), EF (p = 0.005), percent fractional shortening (p = 0.015), and
LV posterior wall in diastole and systole (p = 0.003 and 0.015, respectively) with long duration
flight.
Decreases in LV diastolic diameter and LV diastolic volume were observed following both
short duration (-4% and -8%, respectively) and long duration (-1.3% and -3.5%, respectively)
flights. There was also a decrease in posterior wall thickness in diastole (p <0.05) and a trend
toward decreased thickness in systole in long duration subjects as compared with those from
short duration. Doppler-derived SV and cardiac output were also decreased more following long
duration missions (-17% and -12%, respectively), compared to short duration ( -5% and -2%,
respectively). When comparing the two groups, the differences between SV and cardiac output
were not significant (p = 0.157 and p = 0.429, respectively). Cardiac output decreased despite a
higher heart rate on landing day in long duration subjects (Table II). Other parameters that
appeared to show a trend following long duration flight, but were not statistically different,
included slight decreases in LV mass, right ventricular dimension, and left atrial diameter. An
increase in the mitral E to A ratio (10%) after the long duration missions was observed, as was a
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decrease in mitral deceleration time (-17.9%). Heart rates were increased by approximately 16%
following short duration missions, whereas after long duration missions the increase was only
6%. During the recovery period (3 - 10 days postflight), there was an overall trend toward a
return to preflight values. None of the recovery parameters reached statistical significance when
compared with preflight or landing day values.
DISCUSSION
This study evaluates the differences in echocardiographic findings between short and long
duration spaceflight. Our results show a significant reduction in M-mode-derived EF and
percent fractional shortening in long duration subjects as compared to short duration subjects (p
<0.05). With only a small decrease in diastolic volume, the decrease in EF and percent fractional
shortening results from a significantly increased LV systolic chamber size. Doppler-derived SV
and cardiac output were also decreased following long duration spaceflight. In a measure of LV
compliance, long duration subjects had increased mitral E to A ratios and decreased mitral
deceleration times. LV mass was slightly decreased in long duration subjects as has been
previously reported during a head-down bedrest study (10). Taken together, these results imply a
decrease in cardiac function following long duration spaceflight and suggest that mission
duration may play a role in cardiac deconditioring.
Previous studies that included echocardiography before and after spaceflight have
predominantly dealt with subjects who flew on short duration missions. Investigators have
shown decreases in LV diastolic volume and SV, but maintained EF and cardiac output (2, 3).
LV mass was also decreased in short duration subjects, but these results were not shown to be
significant (3). Recovery from such changes has differed between studies. Following 4- to 5-
day flights Mulvagh et al. reported cardiac changes that were resolved within 48 hours (2). In
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contrast, Bungo et al. reported a more delayed recovery of 1 to 2 weeks following flights of 5 to
8 days (3). Despite the differences in the recovery data, both studies showed minimal difference
between preflight and recovery data. The results from short duration subjects in the present
study are similar to those of the previous studies.
Echocardiography has also been previously performed before and after long duration
spaceflight on both American and Soviet/Russian missions. The results from the long duration
flights have been equivocal. Atkov et al. studied 15 cosmonauts before, during and after (within
24 hours of landing) flights onboard the Soviet Union Space Stations ranging from 75 to 185
days. The results of this study varied widely, with EF changes from pre- to postflight ranging
from -6% to +34% (8). This range led to an overall improvement in EF of 7% being reported
following flight. M-mode echocardiography was performed on 3 astronauts before and after an
84-day flight onboard the American Skylab 4 in 1974 (5). The findings from the present study
included reduced SV and LV diastolic volume and mass. Contrary to the previous studies, data
from this investigation showed a significant reduction in EF as well as a significant increase in
LV systolic volume. Unlike earlier studies, our results included spectral Doppler data that
appeared to show similar trends as that acquired from the imaging data (reduced SV and cardiac
output).
During spaceflight, the demands on the heart are probably reduced compared to preflight.
This reduction could be attributed to a number of factors. The absence of gravity reduces the
perfusion demand for skeletal muscles involved in maintaining upright posture. Overcoming the
gravity-induced hydrostatic gradient involved in perf ising areas distal to the heart is eliminated.
In addition to this hydrostatic gradient, for a subject in the supine position, there is gravity-
induced pressure on the chest wall, which potentially increases intrathoracic pressure and central
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venous pressure.	 In microgravity, this pressure is removed, resulting in decreases in
intrathoracic pressure and central venous pressure, thus possibly aiding venous return. Buckey et
al. showed that during the first 9 hours of spaceflight central venous pressure is decreased
relative to preflight levels (11). Similar findings have been reported during the microgravity
induced by parabolic flight (12). Under these new conditions, it is reasonable to assume that the
heart would adapt, reaching a new, less dynamic equilibrium point.
With a decrease in cardiac output or peripheral arterial resistance, one would also expect
activation of neurohumoral reflexes. Atrial naturetic factor might be expressed by initial
distention caused by decreases in venous pooling and increased blood volume in the thorax. This
should produce an antagonist effect upon the renin-angiotensin system. Over the longer
duration, unloading of high-pressure baroreceptors in the LV, carotid sinus, and aortic arch
would generate afferent signals stimulating the brain cardioregulatory centers. The efferent
sympathetic nervous system would subsequently stimulate the release of renin and angiotensin Il
(and by effect also aldosterone). Concurrent stimulation of the supraoptic and paraventricular
nuclei would result in arginine vasopressin release. Aldosterone has been implicated in
myocardial fibrosis and angiotensin II, in addition to constricting blood vessels and stimulating
aldosterone release, also causes remodeling of cardiac myocytes (13).
The unloading of the heart resulting from a decrease in blood volume would naturally
decrease ventricular volume. The resultant decreased wall stress might subsequently affect
diastolic function with resultant loss of diastolic negative pressure and decreased ventricular
distensibility (14).
Compounded with these conditions was the fact that the long duration subjects in this study
underwent a decrease in aerobic activity as they were often unable to follow the recommended
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exercise regimen, sometimes for weeks at a time. This relative inactivity would decrease
chronotropic and pressure work of the myocardium. Although during short duration flight,
astronauts also do not necessarily exercise strenuously. Therefore any potential effect would
have been less noticeable due to the limited duration of these missions. Taken together, these
factors provide potential mechanisms that could lead to progressive deconditioning of the heart
in microgravity.
Upon return to gravity, there was an increase in mean arterial pressure in both short and long
duration subjects compared to preflight (Table II). This increase in blood pressure could
partially explain a decrease in SV as the heart is working against a greater afterload. However,
similar increases in mean arterial pressure were noted in both the short and long duration
subjects. Thus, it appears that afterload has little effect on the relative decrease in SV following
short vs. long duration spaceflight. The decrease in plasma volume also was between -9% and -
12% in both short and long duration crewmembers (unpublished data, Janice M. Fritsch-Yelle),
indicating that changes in plasma volume were also unlikely to have been responsible for the
difference in SV between groups. The effect of gravity on the chest wall has been shown to have
measurable effects on the central venous pressure (11). Central venous pressure in space has
only been studied in relation to short duration flight, but if central venous pressure remains
reduced throughout long duration flight, the additional time spent in microgravity would lead to
a heart more thoroughly adapted to a reduced intrathoracic pressure. A chronic state of
decreased intrathoracic pressure could potentially lead to remodeling of the heart. This
remodeling could potentially account for the smaller decrease in LV diastolic volume following
long duration when compared to short duration flight. With LV diastolic volume approximately
at preflight levels and a decrease in demand for blood (reduced EF and SV), the LV systolic
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volume would be larger than preflight, similar to our findings.
Long duration-induced cardiac remodeling may also explain why the mitral E to A ratio in
long duration flight tended to increase (10%). The mitral E to A ratio is a measure of the relative
contributions of ventricular relaxation and atrial contraction to LV filling. We initially believed
that the decrease in plasma volume would lead to diminished preload and result in a decreased E
to A ratio. The increased E to A ratio following long duration flight was not expected and
would suggest increased cardiac compliance. This idea is supported by a study that was
performed on rhesus monkeys in simulated microgravity (10° head-down tilt for 4 days). These
authors found increased cardiac compliance and decreased LV contractility after head-down tilt
(15). However, with LV diastolic volume at nearly preflight levels, and an increased LV systolic
volume (i.e. decreased EF), LV diastolic relaxation would necessarily be somewhat restricted as
compared'to preflight, reducing the potential atrial contraction component to LV filling.
A quick recovery of functional parameters postflight would argue against structural
myocardial changes and support neurohumoral effects. Autonomic regulation of cardiovascular
function has been shown to be altered on landing day following short duration spaceflight (16,
17). Plasma catecholamine levels are increased on landing day in short duration flight subjects;
this may explain the significant increase in heart rate (16-18). In contrast, it appeared the heart
rate response was attenuated in long duration flight subjects. Taken together, the data indicate
that autonomic regulation of cardiac function may be decreased in long duration flight subjects
which may also contribute to the observed decrease in cardiac function (EF). This could also
play a role in suboptimal postflight cardiac performance (17). A previous study of heart rate
variability was unable to define the relative changes in the effects of the autonomic nervous
system with long duration flight (19).
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The small number of subjects available for this study does not allow extrapolation of its
results to a larger population. Additional studies are required, with a larger and more diverse
subject pool, to determine whether changes observed in this study are reproducible and, if so,
what factors (gender, exercise, diet, or cabin environment) alleviate or exacerbate cardiovascular
deconditioning.
Our study assumes that the environments of the Space Shuttle and Mir Space Station did not
influence the cardiovascular system in any way beyond the effects of microgravity. It is widely
known, however, that Mir has experienced numerous environmental problems. These included,
at their most extreme, ethylene glycol leaks, a fire, disturbances in carbon dioxide balance, and
very high humidity. It is not known whether these and other environmental factors could have
impacted cardiac performance.
Certain, newer techniques, such as tissue Doppler imaging or color flow propagation, were
not used due to limitations of the available equipment. It is certainly recognized that these
techniques could help better characterize the changes in cardiac structure and function. The
relatively older equipment and the existing protocol necessitated the calculation of ventricular
volumes from M-mode. Although this technique is not accurate as an absolute measure of LV
volume in disease conditions, it does provide a dependable measure of healthy, symmetrically
shaped hearts, especially in a longitudinal study.
CONCLUSIONS
The most interesting findings of our study were the greater long duration reductions in EF,
SV, and cardiac output, and an increase in LV systolic volume when compared to short duration
spaceflight. These findings suggest greater cardiac deconditioning with long duration than with
short duration spaceflight. This raises important concerns regarding progressive reduction in
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cardiac function with increased mission duration. The findings from Doppler evaluation of SV
and cardiac output support the findings from the M-mode and two-dimensional LV evaluation.
The exact cause or causes of these findings cannot definitively be determined from this study
and need to be confirmed with a larger group of long duration crewmembers, including in-flight
echocardiography. If this trend is borne out in subsequent studies, it could have an important
impact on mission duration decisions, as well as on countermeasure programs.
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MINI ABSTRACT
Comparison of Echocardiographic Measurements Before and After Short and Long
Duration Spaceflight.
David S. Martin, Donna A. South, Margie L. Wood, Michael W. Bungo, Janice M. Fritsch-Yelle
Echocardiographic findings before and after short and long duration spaceflight were
compared. Decreases in ejection fraction, stroke volume, cardiac output and an increase in left
ventricular systolic volume are suggestive of a decrease in cardiac function related to mission
duration.
Table I Echocardiographic parameters (mean ± SE) before flight, on landing day and 2-4 days
after landing (recovery) for short and long duration flight crew members. * = p < 0.05 from
preflight within a group.
Short duration (n=13) Long duration (nom)
Preflight Landing day Recovery Preflight Landing day Recovery
RVDD (cm) 2.60 ± 0.12 2.61	 ±	 0.16 2.45 ± 0.16 1.99 ± 0.23 1.81	 ±	 0.26 1.98 ± 0.26
IVSD (cm) 1.00 ± 0.04 1.03 ±	 0.03 1.08 ± 0.04 0.92 ± 0.06 0.90 ±	 0.06 0.98 ± 0.04
rVSS (cm) 1.39 ± 0.04 1.45 ±	 0.05 1.47 ± 0.04 1.33 ± 0.07 1.31	 ±	 0.13 0.96 ± 0.15
LVDD (cm) 5.28 ± 0.16 5.09 ±	 0.11 5.15 ± 0.13 5.41 ± 0.24 5.34 ±	 0.25 5.13 ± 0.15
LVDS (cm) 3.27 ± 0.12 3.02 ±	 0.08 3.12 ± 0.09 3.14 ± 0.23 3.35 ±	 0.22 3.02 ± 0.20
FS (%) 38.00 ± 0.01 41.00 ±	 0.01 39.00 ± 0.01 42.00 ± 3.20 37.58 ±	 1.33 42.00 ± 2.29
LV PWD (cm) 0.87 ± 0.02 0.93 ±	 0.02 0.95 ± 0.01 1.00 ± 0.06 0.86*±	 0.04 0.95 ± 0.04
L V P WS (cm) 1.58 ± 0.05 1.61	 ±	 0.04 1.66 ± 0.04 1.66 ± 0.09 1.43 ±	 0.08 1.46:L 0.04
MCS (circ/sec) 1.08 ± 0.03 1.17 ±	 0.04 1.07 ± 0.03 1.28 ± 0.09 1.14 ±	 0.09 N/A
LAD (cm) 3.70 ± 0.11 3.71	 ±	 0.09 3.65 ± 0.14 3.67 ± 0.16 3.52 ±	 0.08 3.65 ± 0.23
MASS (gm) 232.00 ± 15.00 231.00 ± 12.00 246.00 ± 15.00 219.00 ± 37.00 192.00 ± 15.00 196.00 ± 11.00
LVVD (ml) 136.00 ± 9.60 123.00 ±	 6.70 127.00 ± 7.30 147.00 ± 23.00 139.00 ± 15.00 128.00 ± 9.20
LVVS (ml) 43.00 ± 4.40 35.00 ±	 2.30 40.00 ± 3.10 40.00 ± 5.60 52.00 ±	 5.70 35.00 ± 3.90
EF (%) 68.00 ± 1.40 71.00*±	 0.01 69.00 ± 0.01 73.00 ± 3.00 65.00*±	 2.95 72.00 ± 0.71
PV (M/sec) 0.83 ± 0.04 0.90 ±	 0.03 0.87 ± 0.04 0.83 ± 0.04 0.88 ±	 0.12 0.98+ 0.03
DVI(cm) 0.17± 0.01 0.16 ±	 0.01 0.20± 0.01 0.15± 0.01 0.17 ±	 0.01 0.17± 0.01
E/A Ratio 1.74 ± 0.14 1.70 ±	 0.07 1.84 ± 0.13 1.39 ± 0.11 1.53 ±	 0.17 1.57 ± 0.22
E (M/sec) 0.60 ± 0.03 0.61	 ±	 0.02 0.60 ± 0.03 0.57 ± 0.05 0.67 ±	 0.12 0.61 ± 0.06
A (M/sec) 0.37 ± 0.02 0.36 ±	 0.01 0.38 ± 0.02 0.42 ± 0.04 0.41	 ±	 0.07 0,40:L 0.02
AT (sec) 0.08 ± 0.01 0.08 ±	 0.01 0.10 ± 0.01 0.08 ± 0.02 0.11	 ±	 0.01 0.08 ± 0.01
DT (sec) 0.22 ± 0.02 0.19 ±	 0.04 0.60 ± 0.01 0.48 ± 0.04 0.28 ±	 0.04 0.29 ± 0.05
Ao PV (M/sec) 0.98 ± 0.04 0.94 ±	 0.04 0.97 ± 0.06 1.10 ± 0.20 0.93 ±	 0.15 0.96 ± 0.04
An AT (sec) 0.12 ± 0.01 0.11	 ±	 0.01 0.11 ± 0.01 0.08 ± 0.01 0.11	 ±	 0.03 0.11 ± 0.05
Ao DT (sec) 0.29 ± 0.04 0.23 ±	 0.01 0.25 ± 0.01 0.25 ± 0.01 0.19 ±	 0.01 0.24 ± 0.01
HR (bpm) 5433 ± 2.15 62.31 •±	 3.71 54.00 ± 2.10 59.00 ± 5.50 63.00 ± 3.50 70.00 ± 3.00
SBP (mmHg) 113.15 ± 2.49 122.31 •±	 3.25 11830 ± 3.49 113.75 ± 3.67 125.25 ± 4.77 118.75 ± 2.73
DBP (mmHg) 73.23 ± 1.52 79.85 t 2.89 75.08 ± 1.73 63.00 ± 5.93 75.75 ± 1.97 68.50 ± 2.58
MAP (mmHg) 86.54 ± 1.47 94.00•± 2.88 89.49 ± 1.82 79.92 ± 5.13 92.25 ± 2.76 85.25 ± 239
SV (ml) 89.77 ± 5.60 81.01 •± 4.80 93.47 ± 6.90 93.59 ± 14.70 7233 ± 6.13 88.46 ± 7.99
CO (Umin) 4.98 ± 0.26 5.02 ± 0.27 5.08 ± 0.37 5.28 ± 0.58 4.62 ± 0.52 6.33 ± 0.53
TPR (mmHg/1/min) 17.57 ± 0.86 19.48 ± 1.16 18.49 ± 1.29 15.75 ± 1.69 21.16 ± 3.25 13.57 ± 2.06
Weight (1b) 178.00 ± 6.53 170.00 ± 5.79 176.00 ± 6.51 176.00 ± 5.77 164.00 ± 7.40 171.00 ± 5.31
Table II Comparison of changes in echo cardiographic parameters between short and long
duration flights. Each column represents the percent change from preflight to landing day. * = p
< 0.05 between short and long duration flights. ** = p < 0.01 between short and long duration
flights.
Short duration
n=13
Long duration
n=4
0 % 0 %
RVDD (cm) 2.00 ± 0.06 -4.30	 0.07
IVSD (cm) 5.00 ± 0.04 1.10	 0.09
IVSS (cm) 6.00 ± 0.02 -1.50
	 0.01
LVDD (cm) -4.00 t 0.02 -1.30	 t 0.01
LVDS (cm) -7.00 ± 0.02 7.40*	 0.05
FS (%) 7.00 ± 0.03 -11.00** ± 0.07
LVPWD (cm) 9.00 ± 0.03 -14.20** ± 0.01
LVPWS (cm) 2.00 f 0.02 -14.00*
	 f 0.05
MCS (circ/sec) 8.00 ± 0.05 -11.00	 t 0.08
LAD (cm) 0.00 f 0.02 -3.60
	 ± 0.03
MASS (gm)' 3.00 f 0.07 -1.20
	 ± 0.08
LVVD (ml) -8.00 ± 0.04 -3.50	 ± 0.06
LVVS (ml) -12.00 f 0.06 39.00** f 0.24
EF (%) 6.00 ± 0.02 - 10.50 ** ± 0.03
PV (M/seC) 12.00 ± 0.05 5.90	 ± 0.07
DVI (cm) 2.00 ± 0.10 8.70	 ± 0.21
E/A Ratio 5.00 ± 0.09 10.30	 ± 0.18
E (M/sec) 3.00 t 0.07 15.30	 t 0.17
A (M/sec) 3.00 ± 0.07 -3.10	 ± 0.08
AT (sec) -3.00 ± 0.08 52.10	 t 0.67
DT (sec) 1.00 ± 0.07 -16.90	 ± 0.08
Ao PV (M/sec) 4.10 ± 0.03 -13.20	 ± 0.09
Ao AT (sec) -7.00 f 0.05 -5.40	 ± 0.11
Ao DT (sec) -13.00 ± 0.15 -27.40
	 ± 0.15
HR (bpm) 15.70 ± 0.09 6.00	 ± 0.10
SBP (mmHg) 6.96 ± 2.47 8.93	 ± 3.12
DBP (mmHg) 6.64 ± 4.12 16.60
	 ± 3.90
MAP (mmHg) 6.76 ± 3.45 13.20	 ± 2.80
SV (ml)
-5.00 ± 0.03 -17.40
	 ± 0.05
CO (Umin) -2.30 ± 0.07 -12.20	 ± 0.09
TPR (mmHg/1/min) 7.13 ± 5.93 25.00
	 ± 3.44
Weight (lb) -2.87 ± 2.99 -2.57
	 ± 3.28
